Several studies have demonstrated a significant association between osteoprotegerin concentrations and endothelial dysfunction, particularly in patients with hyperuricemia (192), type 2 diabetes mellitus (193), and HIV infection (194). Here, TNFRSF11B is linked to type 2 diabetes mellitus.